Boston Scientific BSX
NYSE BSX
$44.97 -0.01 (-0.02%)
As of: Sep 9, 2026 · 3:59 PM EDT

Boston Scientific (BSX) Other Non-Current Assets (2009 - 2026)

Boston Scientific's (BSX) quarterly Other Non-Current Assets came in at $45.2 billion in Q2 2026, up 8.8% year-over-year from $41.6 billion in Q2 2025, and up 1.95% quarter-over-quarter from $44.4 billion in Q1 2026.

Analysis

Boston Scientific (BSX) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Boston Scientific has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $45.2 billion for Q2 2026.

  • In Q2 2026, Other Non-Current Assets rose 8.8% year-over-year to $45.2 billion; the TTM figure through Jun 2026 stood at $45.2 billion (up 8.8% YoY), while the FY2025 annual figure was $43.7 billion, up 10.86% from the prior year.
  • Other Non-Current Assets came in at $45.2 billion for Q2 2026 at Boston Scientific, up from $44.4 billion in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $45.2 billion in Q2 2026 to a low of $1.4 billion in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $21.0 billion, with a median of $17.1 billion recorded in 2022.
  • Year-over-year, Other Non-Current Assets fell 19.78% in 2022 and soared 2579.5% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $32.5 billion in 2022, then rose by 8.21% to $35.1 billion in 2023, then climbed by 12.12% to $39.4 billion in 2024, then climbed by 10.86% to $43.7 billion in 2025, then gained by 3.53% to $45.2 billion in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $45.2 billion in Q2 2026, $44.4 billion in Q1 2026, and $43.7 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 4.32 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 3.23 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 616.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 434.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 273.70 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 215.10 Mn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn 1.08 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45.22 Bn
Mar 31, 2026 44.35 Bn
Dec 31, 2025 43.67 Bn
Sep 30, 2025 42.71 Bn
Jun 30, 2025 41.56 Bn
Mar 31, 2025 40.14 Bn
Dec 31, 2024 39.40 Bn
Sep 30, 2024 1.64 Bn
Jun 30, 2024 1.55 Bn
Mar 31, 2024 1.60 Bn
Dec 31, 2023 35.14 Bn
Sep 30, 2023 1.61 Bn
Jun 30, 2023 1.60 Bn
Mar 31, 2023 1.48 Bn
Dec 31, 2022 32.47 Bn
Sep 30, 2022 1.60 Bn
Jun 30, 2022 1.57 Bn
Mar 31, 2022 1.38 Bn
Dec 31, 2021 1.41 Bn
Sep 30, 2021 1.44 Bn